In our analysis, we find that 26.9% of patients dominantly expressed the transcriptional dysregulation phenotype, potentially linking ALS-TD patients and cryptic exon expression in UNC13A – although additional work is needed to determine if cryptic exon expression is specific to ALS-TD. The gene discussed is UNC13A; the disease is amyotrophic lateral sclerosis.